Podcasts about canadian institute

Qualitycast North is excited to bring you a special 4-episode series celebrating the 25-year anniversary of The Royal Commission on the Future of Health Care in Canada and the subsequent, ground-breaking, Romanow Report. About the Royal Commission and Romanow ReportIn 2001, the Federal government launched the landmark Romanow Commission, to examine the future of Canada's publicly funded healthcare system. Led by Roy Romanow, the Commission combined extensive research, expert analysis, and one of the largest public consultations in Canadian healthcare history. Through engagement with healthcare professionals, governments, Indigenous organizations, and tens of thousands of Canadians, the Commission developed evidence-based recommendations aimed at strengthening the sustainability and accessibility of Medicare for future generations.We're continuing our special series with this our third interview. Giving us insights into the relevance of the Report at the Provincial level and a masterclass in delivering high-impact health care system improvement on a Provincial scale is today's guest, Dr. Verna Yiu. Dr. Yiu, a pediatric nephrologist by training, is the current Board Chair of CIHI, the Academic Dean and Provost of The University of Alberta and the former CEO of Alberta Health Services from 2016 to 2022. In this episode, Dr. Yiu explains what she found inspiring about the Report before sharing her experience of successfully implementing large-scale improvements in healthcare delivery and how these can be applied in other jurisdictions. We also hear about the foundational importance of primary care, patient centered care and data system integration to delivering high quality and cost effective health care.Join us for the fourth and final part of this special series in which we talk to Dr. Gordon Hoag, Senior Provincial Quality Improvement Co-Lead about the spirit of the Romanow report and its ephemeral relevance for Canadian healthcare today. Listen now: The spirit of the Romanow Report lives on - improving health care in British Columbia today” featuring Dr. Gordon Hoag, Senior Physician Quality Improvement Co-LeadLinks:Commission on the Future of Health Care in Canada: The Romanow Commission (Government of Canada)The Romanow Report (download)Canadian Institute for Health Information (CIHI)University of AlbertaAlberta Health ServicesThe Specialist Services CommitteeQualitycast NorthSpecial Series Credits:Hosts: Dr. Shyr Chui, Dr. Eiko WaidaExecutive Producer: Aman HundalProducer: Lee CameronTechnical Support: Mat Walker (Expression North), Stefanie GarrawayPart 1. The Rt. Honorable Jean Chrétien, former Prime Minister of Canada (Listen now)Part 2.  Greg Marchildon, former Chief of Staff to Roy Romanow (Listen now)

This episode of the IHSA Safety Podcast discusses how workplace health and safety research is being translated into practical tools that employers and workers can use to improve safety outcomes across Ontario, and features Rod Cook, Vice President of Workplace Health and Safety Services at WSIB, and Dr. Amin Yazdani, President of the Canadian Institute for Safety, Wellness and Performance (CISWP).Rod shares how the WSIB is investing in research and partnerships to better understand the root causes of workplace injuries and support prevention-focused solutions across sectors. Dr. Amin explains how CISWP's applied research approach brings data collection directly to job sites through mobile labs and advanced technologies, helping generate insights based on real working conditions.Together, they discuss how research findings are being translated into practical, accessible tools that employers can use to strengthen their health and safety programs. They highlight the importance of collaboration between organizations, researchers, and industry in driving meaningful improvements in workplace safety, and explain how employers, supervisors, and health and safety professionals can use research-informed tools and resources to support safer workplaces.Free resourcesWSIB Health and Safety Excellence ProgramWorkplace Safety and Insurance Board (WSIB)WSIB Online ServicesCanadian Institute for Safety, Wellness and Performance (CISWP)CCOHS Business Safety PortalSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

If you live in Western Canada, your community faces elevated wildfire or smoke risk this season — and the window for conditions to worsen is short. Emergency Management Minister Eleanor Olszewski and Environment Minister Julie Dabrusin delivered the troubling news in their latest wildfire readiness briefing, adding they expect a hot and dry summer ahead, while maintaining the federal government is prepared. They also say the West is facing its highest fire danger in years, including many First Nations communities – still struggling to recover from a devastating 2025.Also: Canada's doctors open up about their ongoing struggles to keep up with the nation's mental health troubles. A Canadian Institute for Health Information report suggests visits to family physicians for psychotherapy and counselling has jumped 50 per cent since 2015, putting an additional strain on a system already stretched thin.And: Lights. Camera. Backlash. The controversy surrounding a new feature film, fully generated by Artificial Intelligence. The movie, ‘Dreams of Violets,' will premiere at the Tribeca Film Festival next month, drawing both public interest, and Hollywood criticism as artists scramble to address the growing use of AI in their industry.Plus: PM Carney in New York, Iran War talks, CFL's streaming deals, and more.

BC's provincial health officer is recommending that alcohol products get a warning label and minimum pricing, based on alcohol content. Dr. Tim Naimi, Director of the University of Victoria's Canadian Institute for Substance Use Research joins the show to talk about what that could look like and the trends in alcohol consumption.

In this episode, Dr Tsen Vei Lim talks to Dr Philip Newall, a Senior Lecturer at the University of Bristol, UK. The interview covers Philip's opinion and debate article on sludge, dark patterns and dark nudges: a taxonomy of online gambling platforms' deceptive design features.The rationale behind Philip's article [01:16]A background on the policy landscape associated with online gambling platforms [06:40]The three features that online gambling platforms use [09:18]The implications of these features for policymakers [14:30]The implications of these features for the gambling industry [17:22]The implications of these features for the people using online gambling platforms [19:46]The end goal of Philip's research [21:24]About Tsen Vei Lim: Tsen Vei is an academic fellow supported by the Society for the Study of Addiction, currently based at the Department of Psychiatry at the University of Cambridge. His research integrates computational modelling, experimental psychology, and neuroimaging to understand the neuropsychological basis of addictive behaviours. He holds a PhD in Psychiatry from the University of Cambridge (UK) and a BSc in Psychology from the University of Bath (UK).About Philip Newall: Philip is a Senior Lecturer at the University of Bristol's School of Psychological Science. Philip completed a PhD at the University of Stirling in 2016, before going on to postdoctoral research fellowships at Technical University of Munich, the University of Warwick, and Central Queensland University's Experimental Gambling Research Laboratory. Philip's research applies concepts and research methods from behavioural science to gambling. Philip was a member of the Advisory Board for Safer Gambling from 2021 to 2025, which was an advisory group of the Gambling Commission in Great Britain. In the last three years, Philip has been a named researcher on projects funded by the Academic Forum for the Study of Gambling, Alberta Gambling Research Institute, Arts and Humanities Research Council, BA/Leverhulme, Canadian Institute for Health Research, Clean Up Gambling, Gambling Research Australia, and the Victorian Responsible Gambling Foundation. Philip has received honoraria for reviewing from the Academic Forum for the Study of Gambling and the Belgium Ministry of Justice, travel and accommodation funding from the Alberta Gambling Research Institute and the Economic and Social Research Institute, and open access fee funding from the Academic Forum for the Study of Gambling and Greo Evidence Insights.Original article: Sludge, dark patterns and dark nudges: A taxonomy of online gambling platforms' deceptive design features https://doi.org/10.1111/add.70085The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.Music provided by Jack Shakespeare. Hosted on Acast. See acast.com/privacy for more information.

When you think of Canadian health data, the organization that springs immediately to mind is the Canadian Institute for Health Information or CIHI. In this episode we interview Anderson Chuck, the President and CEO of CIHI, about how Canada is “data rich but information poor” and how using Pan-Canadian health data in the right way can drive improvements in health care quality. We also discuss how adopting the right data "mindset" can ensure sustainable Canadian healthcare in the future and improve economic resilience and prosperity for Canada as a nation.Links:CIHI(En)CIHI(Fr)Canadian Health Information Podcast

This episode features Dr. Bernice Downey. Dr. Downey is a woman of Ojibwe and Celtic heritage, a mother, and a grandmother. She is a medical anthropologist whose current research interests include Indigenous women's heart health, health literacy, Indigenous Traditional Knowledge, and health and research system reform for Indigenous populations. She is a Heart & Stroke Foundation-CIHR Early Career Chair in Indigenous Women's Heart and Brain Health. She is also the inaugural Associate Dean, Indigenous Health for the Faculty of Health Sciences, and a former Acting Director of the McMaster Indigenous Research Institute. Dr. Downey has participated in multiple national and international Indigenous research policy initiatives, including serving as a two-term member of the Canadian Institutes of Health Research's Institute of Aboriginal Health Advisory Board, helping plan and participate in the International Network of Indigenous Health Knowledge Development, and serving as Chief Executive Officer of the National Aboriginal Health Organization, whose mandate included a strong research and knowledge translation focus. As part of her post-doctoral fellowship role with the Department of Graduate Studies at McMaster, Dr. Downey led the development of the innovative Indigenous Undergraduate Summer Research Scholars Program and the McMaster Indigenous Research Institute.

With ancestral roots in post-colonial Punjab and Kashmir, Somia Sadiq is a leading Planner who has developed a pioneering practice in engagement, conflict transformation, and negotiating space for those whose voices are often unheard or ignored. Rooted in the work of impact assessment, Somia founded Narratives, an award-winning planning and design firm that emphasizes human-centric, trauma-informed story work, lived experience, and creating space for celebration of ancestral identity. Somia is also the founder of Kahanee and Ravayat, a non-profit organization that amplifies storytelling and dialogue for peacebuilding.Somia began her professional planning career undertaking impact assessment with a focus on resource, energy, and infrastructure projects. Her Doctorate focuses on understanding the role of Identity, Othering, and Trauma in conflict transformation. She is a writer and a keynote speaker, offering insights on trauma-informed leadership, and fostering resilience in a rapidly changing environment. Recognized for her contributions to the Planning practice in Canada and internationally, Somia was recently inducted into the Canadian Institute of Planners' esteemed College of Fellows, the highest honour for a planner in Canada. Gajarah, her debut novel, is a powerful testament to the power of storytelling in fostering resilience rooted in identity and ancestral strength.

On a new episode of the Gaming News Canada Show presented by Bede Gaming, Steve McAllister is joined by two of the leading voices in the just-released research on sports betting advertising and its impact on young men. Dr. Andrew Kim, psychology professor at Toronto Metropolitan University and Canada Research chair in addictions and mental health comorbidity, and Greo Evidence Insights chief research officer Matthew Young discussed with McAllister the findings of the research that was conducted in Alberta and Ontario. TMU and Greo received a helping hand from Brock University, the University of Calgary, the University of Massachusetts Amherst and the University of Bristol, with funding provided by the Canadian Institutes of Health Research and the Alberta Gambling Research Institute. Among the topics discussed:The genesis of the study, and how the funding was secured.The effect of sports betting advertising, especially on men under 30, and how those ads motivate young gamblers to play online casino games.The effectiveness of responsible gaming advertising.The need for problem gambling to be identified as a public health issue.Thoughts on placing additional restrictions on gambling advertising. The efforts by the authors of the research to get the results in front of gambling industry stakeholders. The need for ongoing research with the Ontario legal market now four years old, and an open, regulated market ready to launch in Alberta this summer. Hosted on Acast. See acast.com/privacy for more information.

Bernie Pauly of the Canadian Institute for Substance Use Research and the University of Victoria speaks about how the toxic drug crisis has unfolded over 10 years as a declared public health emergency. Also featuring the voices of Amanda Farrell-Low, Stephanie Harrington, and Sarah Lee.

In this episode, Dr Elle Wadsworth talks to Dr André McDonald, postdoctoral fellow at McMaster University's Peter Boris Centre for Addictions Research, Canada. The interview covers André's research article looking at adolescent cannabis use and psychological distress from 2013 to 2023 using a population-based study in Ontario, Canada.Psychological distress and why it is important with regards to cannabis [01:19]Why cannabis potency is important in the relationship between psychological distress and cannabis [02:06]The prevalence of youth cannabis use over the decade of the study [03:54]The Ontario Student Drug Use and Health Survey [04:45]The key findings of the study [05:24]The results of additive and multiplicative interactions [07:07]Unpacking the dose-response curve among females [09:07]The implications of the findings for policy [11:31]The limitations of the study [12:29]Take home messages of the study [14:00]About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health. About André McDonald: André, PhD, MPH, is an epidemiologist and postdoctoral fellow at McMaster University's Peter Boris Centre for Addictions Research. André's research examines the intersection between mental health and addictions among youth, with a focus on the link between cannabis use and risk of mood, anxiety, and psychotic disorders. André completed his PhD at the University of Toronto and is currently supported by a Fellowship from the Canadian Institutes of Health Research (CIHR).Original article: Adolescent cannabis use and psychological distress from 2013 to 2023: A population-based study in Ontario, Canada https://doi.org/10.1111/add.70333The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.Music provided by Jack Shakespeare. Hosted on Acast. See acast.com/privacy for more information.

Listen to today's podcast... Part of spring cleaning is tackling your cupboards and drawers.  Well how about that medicine cupboard? Do You Know About Medication Safety? I know that mine had been neglected when I found a jar of Vicks medicated rub from when I was a kid.  Yes, that was a long time ago and yes, it was about time that it was thrown out.  I have no idea if that stuff ever goes bad, but I probably should have thrown it out years ago.  I have carted it from my bedroom, to my residence room, to my first apartment, and then from one home to the next with my family. Medication errors are said to affect at least 1.5 million Canadians per year according to the Canadian Institute for Health Information.  And those mistakes can be disastrous. Medication safety isn't just about an expiry date.  It's about safe storage.  Knowing what medications may interact with other medications, food and supplements. It's about telling your doctor about any side effects you may have had from previous prescriptions and what supplements or over-the-counter medications you may be taking. Take One Action Today To Build Your #Resiliency!      Here are today's Tips For Building Resiliency and Celebrating Medication Safety Week: Check your prescriptions periodically for expiration dates Don't share medicines with friends or family Dispose of medications properly. Most pharmacies will take your old drugs for proper disposal. Avoid putting them in trashcans or into the toilet Remember that the term “natural” does not necessarily mean “safe”.  Treat all supplements and herbal remedies with the same respect as you would any prescribed medications  Make Sure That Your Family Stays Safe And Healthy Want to find more strategies to coping with stress? Check out my website at worksmartlivesmart.com #mentalhealth #hr

เอริก แธร์ริยอง (Eric Therrien) ผู้อำนวยการห้องสมุดกาเบรียล-รัว, แคนาดา สำเร็จการศึกษาระดับปริญญาโทด้านบรรณารักษศาสตร์และสารสนเทศศาสตร์ และทำงานกับสถาบัน Canadian Institute of Quebec ซึ่งเป็นองค์กรวัฒนธรรมที่ดูแลเครือข่ายห้องสมุดเมืองควิเบกมาตั้งแต่ปี 2004 โดยได้ผ่านบทบาทหน้าที่หลากหลายภายในองค์กร ตลอดระยะเวลาที่ผ่านมา เขามีบทบาทสำคัญในการบริหารคอลเลกชันและการกำหนดยุทธศาสตร์ดิจิทัลของห้องสมุดเมืองควิเบก และขับเคลื่อนโครงการปรับปรุงห้องสมุดหลายแห่ง นอกจากนี้ เอริกยังเคยดำรงตำแหน่งประธานองค์กร BIBLIOPRESTO.CA และเป็นผู้พัฒนาแพลตฟอร์มให้ยืมหนังสือดิจิทัล PRETNUMERIQUE.CA และมีส่วนร่วมในการจัดทำนโยบายใหม่สำหรับห้องสมุดประชาชนในรัฐควิเบก สะท้อนบทบาทผู้นำด้านการพัฒนาห้องสมุดร่วมสมัยที่ให้ความสำคัญกับการเข้าถึง เทคโนโลยี และการมีส่วนร่วมของชุมชนซึ่งสะท้อนให้เห็นถึงบทบาทผู้นำที่ให้ความสำคัญกับใช้เทคโนโลยี ฟังการบรรยายเรื่อง “Co-designing Inclusive Libraries and Human-Centered Learning Spaces” โดย เอริก แธร์ริยอง (Eric Therrien), แคนาดา

Sleep problems are one of the most common and most frustrating experiences for people living with AiArthritis diseases. In this episode, Eileen Davidson breaks down why getting a good night's rest can feel nearly impossible when you're living with an AiArthritis disease, and shares what has actually helped her along the way.   Eileen explores the many reasons sleep is so disrupted by AiArthritis diseases, from pain and stiffness to the role that chronic inflammation plays in interfering with the body's natural sleep cycles. She offers an honest, personal reflection on what sleepless nights really look like from a patient's perspective and why this issue deserves more attention in conversations about disease management.   Whether you're lying awake wondering if anyone else understands what you're going through, or you're looking for practical steps to try tonight, this episode offers both validation and real, actionable guidance from someone who lives it every day.     Episode Highlights: Why sleep is uniquely challenging for people living with AiArthritis diseases The connection between inflammation and disrupted sleep A personal reflection on what sleep struggles really feel like Small, realistic habits and strategies that can actually make a difference   Links & Resources Have questions about this episode or topics you want to hear us bring to the table? Email us at podcast@aiarthritis.org  Donate to Support the Show: www.aiarthritis.org/donate   Follow AiArthritis on all social media platforms @IFAiArthritis Sign up for our Monthly AiArthritis Voices 360 Talk Show newsletter! HERE   Connect with our Co-Hosts: Eileen Davidson is a rheumatoid arthritis patient advocate from Vancouver Canada. She volunteers with the Arthritis Research Canada patient advisory board and the Canadian Institute of Health Research - Institute of Musculoskeletal Health and Arthritis patient engagement research ambassador, among others. When not advocating she is writing about her experience with arthritis through Creaky Joints, Healthline, Chronic Eileen or can be found being a mom to her son Jacob.   Connect with Eileen: Twitter: @ChronicEileen  

In this episode of the Society of Actuaries Research Institute's Research Insights Podcast, Dale Hall speaks with Michael Bean, FSA (also a member of the Casualty Actuarial Society and the Canadian Institute of Actuaries) about the 2026 Emerging Risk Survey Results. Drawing on input from 100+ senior risk leaders—including Chief Risk Officers, Chief Actuaries, lead consulting partners, and other C-suite decision-makers—Michael shares what risk executives see as most impactful in 2026 and what they believe could matter three or more years out. Listeners will hear why economic and geopolitical risks are driving near-term concern, why technological risks (especially adverse AI outcomes) dominate the longer-term view, and which risk combinations (like cyber + AI and financial volatility + AI) leaders believe could create the toughest scenarios to manage. 2026 Emerging Risk Survey Results

What if your heartbeat could help determine your dementia risk? The CAIDE dementia risk score has long helped clinicians estimate midlife risk for dementia using cardiovascular health factors, but its accuracy hasn't been equal across populations. New research suggests that integrating resting heart rate meaningfully improves predictive performance across most racial groups. In this interview, Dr. Newman Sze and Shakiru Alaka join us to dig into how and why resting heart rate enhances CAIDE's accuracy, what the data shows across different racial groups, and what this could mean for earlier, more equitable identification of dementia risk in both research and clinical settings. Guests: Newman Sze, PhD, professor of health sciences, Brock University, Canada Research Chair in Mechanisms of Health and Disease, and Shakiru Alaka, MS, senior analyst, Canadian Institute for Health Information, data scientist, Western University Show Notes Read Shakiru and Dr. Sze's study, “Enhancing the validity of CAIDE dementia risk scores with resting heart rate and machine learning: An analysis from the National Alzheimer's Coordinating Center across all races/ethnicities,” published in Alzheimer's & Dementia online. Learn more about Shakiru and Dr. Sze's research from this article on the Brock University website. Learn more about Dr. Sze and his research from his bio on the Brock University website. Look into more of Shakiru's research from his Google Scholar page. Connect with us Find transcripts and more at our website. Email Dementia Matters: dementiamatters@medicine.wisc.edu Follow us on Facebook and Twitter. Subscribe to the Wisconsin Alzheimer's Disease Research Center's e-newsletter. Enjoy Dementia Matters? Consider making a gift to the Dementia Matters fund through the UW Initiative to End Alzheimer's. All donations go toward outreach and production. Learn about and pre-order Dr. Chin's book, When Memory Fades: What to Expect at Every Stage, from Early Signs to Full Support for Alzheimer's and Dementia, out June 2, 2026.

In this episode of Beyond The Abstract, Dr. Matthew Sloan sits down to discuss findings from his recent article Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine featured in the November/December issue of the Journal of Addiction Medicine. Join us as Dr. Sloan shares insights into his study investigating the feasibility of delivering symptom-triggered alcohol withdrawal management over telemedicine.   Dr. Matthew Sloan is a clinician scientist at the Centre for Addiction and Mental Health in Toronto, Ontario, Canada. He specializes in the treatment of substance use disorders and their psychiatric comorbidities. He completed medical school and psychiatry residency at McGill University followed by a postdoctoral fellowship in human psychopharmacology at the National Institutes of Health and an addiction psychiatry fellowship at Yale University. Dr. Sloan's primary research interests are developing innovative new treatments for substance use disorders and exploring determinants of psychopharmacological response to drugs of misuse. He has obtained competitive research funding from the Canadian Institutes of Health Research, Health Canada, and the Centre for Addiction and Mental Health Discovery Fund and has received scientific prizes from the American Academy of Addiction Psychiatry and the National Institute on Alcohol Abuse and Alcoholism.   Article Link: Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine

As part of our official DealFlow Discovery Conference Interview Series, produced by Mission Matters, along with our partner DealFlow Events, we're showcasing the innovative companies presenting at the upcoming DealFlow Discovery Conference (January 28-29, at the Borgata in Atlantic City) and the executives behind them. In this episode, Adam Torres interviews Gordana Slepcev, CEO of Lomiko Metals, about the company's critical-minerals projects in Quebec and Newfoundland. Gordana shares Lomiko's mission to develop graphite, rare earths, and other strategic materials to support North America's energy, battery, and technology supply chains while creating long-term value for shareholders and local communities. About Gordana Slepcev Gordana Slepcev, M.Sc.P. Eng, is a Professional Mining Engineer registered in Ontario with more than 25 years of global mining experience in developing, building, and leading safe mining operations. Ms. Slepcev's extensive experience spans multiple commodities, including gold, base metals, coal, and industrial minerals. She brings considerable experience in mineral exploration, permitting, corporate and regulatory/First Nations/ Indigenous relations, and project financing to Lomiko. Before joining the Company, Ms. Slepcev held the position of COO for BMSI, a privately held company, where she was responsible for restarting the barite reprocessing facility, mitigating historical environmental impacts, and overseeing EPCM contractors. She also formerly held the role of COO of Anaconda Mining, where she was responsible for the company's operations and development of the Goldboro project. Ms. Slepcev graduated from the University of Belgrade with a M.Sc. and is the past Chair of the Toronto Chapter of the Canadian Institute of Mining, Metallurgy, and Petroleum (CIM). She is a WTPEO committee member and a member of the Advisory Board of the OreBit platform. About Lomiko Metals Lomiko Metals has a new vision and a new strategy in new energy. Lomiko represents a company with purpose—a people-first company focused on manifesting a world of abundant renewable energy using Canadian and Quebec critical minerals as a solution for North America. The company's goal is to create a new energy future in Canada by growing the critical minerals workforce, becoming a valued partner and neighbour within the communities in which it operates, and providing a secure and responsibly sourced supply of critical minerals. Lomiko is actively developing two main projects in the province of Quebec: La Loutre, which is held 100% by Lomiko and is being explored for high-grade large flake graphite Bourier, which has been optioned by Lomiko and is being explored for lithium Both graphite and lithium are essential to supplying North America's rapidly expanding electric battery and green energy industries. This interview is part of our effort to help investors discover compelling companies ahead of the event — and to help CEOs introduce their story to the 1500+ conference attendees. Learn more about the event and presenting companies:⁠https://dealflowdiscoveryconference.com/⁠ Follow Adam on Instagram at ⁠https://www.instagram.com/askadamtorres/⁠ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: ⁠https://missionmatters.lpages.co/podcastguest/⁠ Visit our website: ⁠https://missionmatters.com/⁠ More FREE content from Mission Matters here: ⁠https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices

About this episode: Citing updated research on the health risks of drinking alcohol, Canada changed consumption guidelines in 2023, making global headlines for its steep drop in what's viewed as "low risk" drinking. In this episode: One of the architects of those guidelines explains how these recommendations were developed, their efficacy as a public health intervention, and what to make of the U.S.'s new guidelines. Guests: Tim Stockwell, PhD, is a scientist at the Canadian Institute for Substance Use Research and emeritus professor of psychology at the University of Victoria. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: US has new alcohol guidelines: How much is healthy to drink?—The Hill Is That Drink Worth It to You?—New York Times Canada's Guidance on Alcohol and Health—Canadian Centre on Substance Use and Addiction What's behind Canada's drastic new alcohol guidance—BBC Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

The Outer Realm Welcomes Special Guest Professor Sylvain Rochon Host: Michelle Desrochers Date: January 8th, 2026 Episode: 665 Discussion: Professor Sylvain Rochon . an award-winning Visionary Leader (2024) and futurist. As one of the founders of The Alliance for Extraterrestrial Diplomatic Contact, he will be discussing this organization whose goal is to build the world's first United Nations recognized embassy for extraterrestrial civilizations. Contact for the show - theouterrealmcontact@gmail.com Michelle Desrochers and The Outer Realm :https://linktr.ee/michelledesrochers_ Please support us by Liking, Subscribing, Sharing and Commenting. Thank you all !!! About Sylvain: Professor Sylvain Rochon, an award-winning Visionary Leader (2024) and futurist. He is one of the founders of the Alliance for Extraterrestrial Diplomatic Contact, an organisation whose goal is to build the world's first United Nations recognized embassy for extraterrestrial civilizations. (Alliance4ET.org) With over 20 years in science, engineering, and technology, including impactful projects with universities globally, Professor Rochon blends visionary thinking with practical application. His work as a visionary-futurist has brought him to start and operate projects that project humanity into a bright and beautiful future. Professor Rochon currently is a Research Fellow at Shinawatra University, a partner at heart-centered consulting firm SJ Performance, LLC , is CEO of the human data intelligence platform, CykoMetrix, collaborator at the Institute of Future Studies and Development (Thailand) and acts as a futurist consultant in his professional life. He holds degrees in biochemistry, chemical engineering, and education. Sylvain has bachelor's degrees in biochemistry, chemical engineering and education. He is also Co-Founder of Cykometrix, the VP of Network Development at the Alliance for Extraterrestrial Diplomatic Contact, Director of the Canadian Institute of Mass Communication, and a delegate of the World Future Society. WEBSITE: www.alliance4et.org If you enjoy the content on the channel, please support us by subscribing: Thank you All A formal disclosure: The opinions and information presented or expressed by guests on The Outer Realm Radio and Beyond The Outer Realm are not necessarily those of the TOR, BTOR Hosts, Sponsors, or the United Public Radio Network and its producers. Although the content may be interesting, it is deemed "For Entertainment Purposes" . We are always respectful and courteous to all involved. Thank you, we appreciate you all!

On this week's episode we discuss reframing pain in the context of osteoarthritis. The purpose of today's conversation is to help you reconceptualise what pain means and shift the dialogue from pain being solely a marker of tissue damage and discusses the nervous system adaptations that occur as pain persists. Further we discuss education programs that target this knowledge and the beliefs that may underlie behaviours that detract from your ability to be physically active and modify your behaviour.Associate Professor Tasha Stanton leads the Osteoarthritis Research Theme within IIMPACT in Health at the University of South Australia, Adelaide. Her research group is affiliated with the Body in Mind Research group in Adelaide (University of South Australia).Tasha completed her PhD at the University of Sydney in 2010 and is currently a National Health & Medical Research Council (NHMRC) Career Development Fellow (2019-2022). She has received over $5.3m in competitive research funding to date, including a highly renowned Canadian Institute of Health Research Postdoctoral Training Fellowship (2011-2014) and NHMRC Early Career Fellowship (2014-2018). Her research aims to understand why we have pain and why, sometimes, pain doesn't go away.RESOURCESJournal articlesA pain science education and walking program to increase physical activity in people with symptomatic knee osteoarthritis: a feasibility studyThe EPIPHA-KNEE trial: Explaining Pain to target unhelpful pain beliefs to Increase PHysical Activity in KNEE osteoarthritis - a protocol for a multicentre, randomised controlled trial with clinical- and cost-effectiveness analysisWebsitesNOI GroupCONNECT WITH USJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Stijn Schmitz welcomes Ross Beaty to the show. Ross Beaty is a Renowned Geologist, Serial Mine Builder & Conservation Advocate. Beaty provides a comprehensive overview of the current gold market and mining industry landscape. He suggests that while gold is currently at record highs around $4,300, the market still has potential for growth, driven by strong macro and supply-demand fundamentals. Beaty anticipates a wave of new gold mine production in 2025-2027 that might eventually dampen prices, but remains optimistic about the sector’s near-term prospects. Drawing from his extensive experience building successful mining companies like Pan American Silver and Equinox Gold, Beaty emphasizes the importance of understanding specific commodity dynamics and investing in projects with significant scale and potential. He highlights the critical factors for successful mining investments, including geological potential, project location, commodity demand-supply fundamentals, and management quality. Beaty candidly discusses the mining industry’s inherent risks, noting that even well-planned projects can face unexpected challenges from geological complexities, political instability, community tensions, and volatile metal prices. He advocates for diversification and strategic portfolio management, as demonstrated by Equinox Gold’s recent divestment of Brazilian assets to focus on tier-one projects and manage debt. Beyond his mining endeavors, Beaty is deeply committed to environmental conservation through his philanthropic work. Timestamps: 00:00:00 – Introduction 00:00:58 – Gold Bull Market Phase 00:03:04 – Exploration Under-Investment 00:05:09 – Lessons from Past Cycles 00:06:40 – Investment vs Mining Differences 00:09:49 – Ross’s Company Categories 00:11:40 – Spotting Special Projects 00:13:20 – Project Evaluation Criteria 00:16:28 – Commodity Fundamentals Analysis 00:21:30 – Common Mining Pitfalls 00:23:00 – Growth and Debt Risks 00:24:05 – Industry Dilution Problems 00:26:30 – Equinox Brazil Divestments 00:29:10 – Future Plans Philanthropy 00:30:23 – Concluding Thoughts Guest Links: Website: https://www.equinoxgold.com Foundation: https://sitkafoundation.org Ross Beaty is a renowned Canadian geologist, mining entrepreneur, and philanthropist with over 50 years of experience in the international minerals and renewable energy sectors. Born in Vancouver in 1951 to a forestry entrepreneur father and a teacher mother, Beaty earned degrees in geology and law from the University of British Columbia, followed by an MSc in geology from Imperial College London. His career began in the 1970s, blending scientific expertise with business acumen to build a legacy of resource innovation. Beaty founded Pan American Silver Corp in 1994, where he serves as Chair Emeritus, growing it into a global leader in silver production. He is currently Chair of Equinox Gold Corp’s Board of Directors, a position he has held since its inception in 2017. Over four decades, he has founded and divested more than a dozen public companies, including Equinox Resources (sold in the 1990s) and Alterra Power Corp, a clean energy firm, generating an estimated $6 billion in shareholder value. A former President of the Silver Institute in Washington, DC, Beaty is a Fellow of the Geological Association of Canada, Society of Economic Geologists, and Canadian Institute of Mining. Beyond business, Beaty is a passionate environmental advocate. He co-founded and presides over the Sitka Foundation, focusing on biodiversity conservation in British Columbia through strategic grants and impact investing. He chairs the BC Parks Foundation, serves as a director for Panthera and the Pacific Salmon Foundation, and is Patron of the Beaty Biodiversity Centre at UBC. His accolades include induction into the Canadian Mining Hall of Fame (2018), the Order of Canada (2017), and an honorary Doctor of Laws from UBC (2018). An optimist at heart, Beaty champions a shift from consumerism to conservation. Married to physician Trisha Beaty, he enjoys beekeeping, cider production, and sea kayaking in Howe Sound. His journey from mining magnate to green evangelist exemplifies resilient entrepreneurship.

Finland, renowned for being the happiest country in the world, has addressed homelessness head-on through a human rights-based approach to housing. Under the Finnish "Housing First" approach, everyone is entitled to a settled place to live, regardless of life circumstances. This system moves away from the goal of making people experiencing homelessness "housing ready," and toward supportive housing units with normal leases and tenancy agreements.   In the fourth episode of this series, host Sarah Rowe is joined by Juha Kahila, Head of International Affairs at Y-Foundation, one of the key national developers of the Housing First principle in Finland. Juha explains why his country chose to adopt this approach, how their housing services provide dignified support to residents, and what other jurisdictions can do to decrease the rate and severity of homelessness in their population.     Guest Juha Kahila, Head of International Affairs, Y-Säätiö (Y-Foundation) Host Sarah Rowe, Legal Counsel, Canadian Institute for the Administration of Justice (CIAJ)

Guaranteeing the right to housing on its own misses a key overlapping concern: whether the housing is actually accessible. Despite the federal government's goal of achieving a barrier-free Canada by 2040, many people continue to face barriers in securing housing that meets their accessibility needs and are twice as likely to live in core housing need. In the third episode of this series, host Sarah Rowe is joined by Marie-Josée Houle, Canada's first Federal Housing Advocate, and Stephanie Chipeur, who holds the Azrieli Accelerator Professorship in Law & Disability Policy at the University of Calgary's Faculty of Law and the School of Public Policy. Together, they discuss the right to adequate housing that is accessible, adaptable, and visitable for people with disabilities, seniors, and other equity-deserving groups.   Guests Stephanie Chipeur, Assistant Professor, Faculty of Law & School of Public Policy, University of Calgary Marie-Josée Houle, Federal Housing Advocate Host Sarah Rowe, Legal Counsel, Canadian Institute for the Administration of Justice (CIAJ)

Guest: Bruce Arthur, Toronto Star columnist In a high-stakes war games exercise held in Toronto, top military officials, health-care leaders, and government representatives gathered behind closed doors to game out a scenario few Canadians can ever imagine; war arriving on our doorstep. The exercise, called Canada Paratus, was a joint initiative led by the Dalla Lana School of Public Health at the University of Toronto, in collaboration with the Canadian Armed Forces, the Canadian Institute for Military and Veteran Health Research, St. Michael's Hospital, and other military-focused organizations. This wasn't about battlefield tactics, but about what happens when Canada's fragile health-care system is pushed to the brink. From mass casualties to logistical chaos, the simulation revealed uncomfortable truths about just how unprepared we are and what it could mean if Canada were drawn into a global conflict where hospitals, not just troops, have to hold the line. This episode was produced by Sean Pattendon

E-scooter injuries are on the rise in Canada, including in children. According to the Canadian Institute for Health Information, between 2022 and 2024, hospitalizations involving e-scooters for kids between five and 17 years old increased by 61 per cent. Dr. Daniel Rosenfield, a pediatric emergency physician at SickKids, says no one under the age of 16 should ride an e-scooter.For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.

Why do older people share more misinformation than young people? Guest: Leaf Van Boven, professor in the Department of Psychology and Neuroscience at CU Boulder Supportive housing site in Surrey Divides Residents Guest: Lionel Wilson is a member of the Semiahmoo South Surrey Coalition How can we help young people understand the sacrifice Canadian Soldiers made? Guest: Nick Held, Scientific Director, Canadian Institute for Military and Veteran Health Research What is Canada's role in the United Nations Climate Conference? Guest: Rick Smith, President of the Climate Institute How to prevent your kids from racking up huge bills Guest: Paul Davis, online safety expert and speaker at socialnetworkingsafety.net Do you get S.A.D.? Guest:  Lina Begdache, Associate Professor of Health and Wellness Studies, Binghamton University Learn more about your ad choices. Visit megaphone.fm/adchoices

Cannabis has come a long way since we last covered it in 2020. With more patients using CBD and medical cannabis to help manage chronic pain, inflammation, anxiety, and sleep issues, it is time for an important update. In this episode, AiArthritis Health Education Manager Leila P. L. Valete is joined by co-hosts and patient advocates Eileen Davidson and Bridget Seritt for a real conversation about what has changed, what we still need to learn, and what patients should know before trying cannabis for autoimmune and autoinflammatory arthritis. The hosts explore how research, attitudes, and medical discussions around cannabis have evolved. They share their own experiences using CBD and cannabis, discuss new findings from rheumatology research, and highlight the ongoing need for better access, safety education, and provider awareness. The conversation also looks at how stigma is shifting as more patients and clinicians see cannabis as a legitimate part of symptom management rather than a last resort. Whether you're new to the topic or already using cannabis as part of your treatment, this episode offers clear guidance, personal insight, and a thoughtful look at its role in patient care.   Episode Highlights: How conversations around cannabis and CBD have evolved since 2020 What new research says about its role in managing pain, sleep, and mental health Patient experiences using cannabis alongside traditional treatments Benefits, risks, and the ongoing debate around medical versus self-directed use How access, education, and stigma continue to shape patient choices   Links & Resources Go With Us! to EULAR 2025: Should Doctors Prescribe Cannabis for Autoimmune Disease?: https://www.youtube.com/watch?v=iw-KJWbKpuo Have questions about this episode or topics you want to hear us bring to the table? Email us at podcast@aiarthritis.org  Donate to Support the Show: www.aiarthritis.org/donate   Follow AiArthritis on all social media platforms @IFAiArthritis Sign up for our Monthly AiArthritis Voices 360 Talk Show newsletter! HERE   Connect with our Co Hosts: Leila is the Health Education Manager at the International Foundation for AiArthritis. She is a person living with Lupus and Sjögren's disease. She is passionate about inclusion and diversity in health education and meeting individuals where they are at in order to learn in a way that resonates with them.    Connect with Leila: Tiktok: @Lupus.lifestyle.lei Instagram: @Lupus.lifestyle.lei   Eileen Davidson is a rheumatoid arthritis patient advocate from Vancouver Canada. She volunteers with the Arthritis Research Canada patient advisory board and the Canadian Institute of Health Research - Institute of Musculoskeletal Health and Arthritis patient engagement research ambassador, among others. When not advocating she is writing about her experience with arthritis through Creaky Joints, Healthline, Chronic Eileen or can be found being a mom to her son Jacob.   Connect with Eileen: Twitter: @ChronicEileen Instagram: @ChronicEileen Facebook: @ChronicEileen   Bridget Dandaraw-Seritt founded a patient based organization that advocates for access to compassionate care and provides community support. She's a published author on therapeutic cannabis, presents at medical conferences, and is engaged in the policy making process. Connect with Bridget: Facebook: Advocates for Compassionate Therapy Now   

On the phone-in: Our guest is Luc Cousineau. He's a professor with the faculty of Recreation and Leisure Studies in the School of Health and Human Performance at Dalhousie University. He's also the co-director of research at the Canadian Institute for Far-Right Studies. Cousineau discusses the dangers of misogyny online for boys. And off the top of the show, we speak with Darlene Compton who's the MLA for Belfast - Murray River, PEI. She talks about the recent problems with the ferry service.

Send us a textNikki Cloutier sits down with Dr. Kimberly Bitz from the Canadian Institute for Public Safety Research and Treatment (CIPSRT) to unpack the tools and resources helping first responders protect their mental health. From PSPNET's online therapy options to CIPSRT's Mental Health Toolkit, Dr. Bitz breaks down practical strategies focused on self-awareness, regulation, connection, and recovery—all designed specifically for public safety personnel. 

Dr. Uri Tabori is a Staff Physician in the Division of Haematology/Oncology, Senior Scientist in the Genetics & Genome Biology program, and Principal Investigator of The Arthur and Sonia Labatt Brain Tumour Research Centre at The Hospital for Sick Children (SickKids). Uri is also a Professor in Paediatrics and Associate Professor in the Institute of Medical Sciences at the University of Toronto. Uri works as a physician treating kids with cancer, particularly brain tumors. Through his research, he is working to identify drugs and make new discoveries that may cure cancers or improve patients' lives. When he's not hard at work in the lab or clinic, Uri enjoys spending time with his family, watching American football, and exploring the wilderness of Canada. He is especially fond of canoeing and canoe camping with his family. He received his MD from the Hadassah School of Medicine of Hebrew University in Israel. Afterwards, he completed a Rotating Internship and his Residency in Pediatrics at the Sorasky Medical Center in Israel. Next, Uri accepted a Fellowship in Pediatric Hematology and Oncology at the Sheba Medical Center in Israel. He served as a Staff Physician in Pediatric Hematology and Oncology at The Sheba Medical Center for about a year before accepting a Research and Clinical Fellowship at The Hospital for Sick Children in Canada SickKids where he remains today. Over the course of his career, Uri has received numerous awards and honors, including the Early Researcher Award from the Ontario Ministry of Development and Innovation, the New Investigator Award from the Canadian Institute of Health Research, the Junior Physician Research Award from the University of Toronto Department of Pediatrics, The New Investigator Award from the Terry Fox Foundation, A Eureka! new investigator award from the International Course of Translational Medicine, A Merit Award from the American Society of Clinical Oncology Annual Meeting, and The Young Investigator Award from the Canadian Neuro-Oncology Society. In our interview, Uri shares more about his life, science, and clinical care.

On October 9, 1975, CBC listeners across the country heard David Suzuki introduce the very first episode of Quirks & Quarks. 50 years and thousands of interviews later, Quirks is still going strong, bringing wonders from the world of science to listeners, old and new.On October 7, 2025 we celebrated with an anniversary show in front of a live audience at the Perimeter Institute for Theoretical Physics in Waterloo, Ontario. We had guests from a range of scientific disciplines looking at what we've learned in the last 50 years, and hazarding some risky predictions about what the next half century could hold. Our panelists were:Evan Fraser, Director of Arrell Food Institute and Professor of Geography at the University of Guelph, co-chair of the Canadian Food Policy Advisory Council, a fellow of the Pierre Elliot Trudeau foundation, and a fellow of the Royal Canadian Geographical Society.Katie Mack, Hawking Chair in Cosmology and Science Communication at the Perimeter Institute for Theoretical Physics.Luke Stark, Assistant Professor in the Faculty of Information & Media Studies at Western University in London, Ontario, and a Canadian Institute for Advanced Research Azrieli Global Scholar with the Future Flourishing Program.Laura Tozer, Assistant Professor of Environmental Studies at the University of Toronto and director of the Climate Policy & Action Lab at the Department of Physical and Environmental Sciences at the University of Toronto Scarborough.Ana Luisa Trejos, a professor in the Department Electrical and Computer Engineering and the School of Biomedical Engineering and Canada Research chair in wearable mechatronics at Western University in London, Ontario.Yvonne Bombard, professor at the University of Toronto and scientist and Canada Research Chair at St. Michael's Hospital, Unity Health Toronto, where she directs the Genomics Health Services Research Program.

How is the BCGEU strike affecting restaurants? Guest:  Bo Chen, Executive Director, Alliance of Beverage Licensees BC Slashing $100 million from next year's operating budget Guest: Pete Fry, Vancouver City Councilor What is Chronic Fatigue Syndrome? Guest: Alexandre Akoulitchev, Director at Oxford BioDynamics Has President Trump brokered a peace deal in the Middle East? Guest: Reggie Cecchini, Global News Washington Correspondent What is the strong borders act, and what does it mean for your privacy? Guest: Michael Geist, Canada Research Chair in Internet and E-Commerce Law at the University of Ottawa Why are so many Canadians getting hurt in hospitals across the country? Guest: Melanie Josee Davidson,  director of health system performance at Canadian Institute for Health information What is a sovereign wealth fund, and why does Canada need one? Guest: John Ruffolo, Founder & Managing Partner, Maverix Private Equity Learn more about your ad choices. Visit megaphone.fm/adchoices

Today, I am delighted to reconnect with two previous guests, Dr. Darren Candow. Dr. Candow is a distinguished professor and an internationally renowned researcher on creatine monohydrate, nutrition, and physical activity, whom I had the pleasure of speaking with on Episode 301, where we discussed creatine.  We are doing an AMA session today, delving into various themes surrounding creatine, from debunking outdated RDA recommendations to exploring the synergies between strength training and creatine efficacy. We examine the cognitive benefits of creatine, investigating its interactions with caffeine and its implications for bone health, hydration, anabolic resistance, and metabolic health.  You will find today's AMA session as enlightening and enriching as I did while recording it. IN THIS EPISODE YOU WILL LEARN: The safety and efficacy of creatine as a supplement How creatine increases muscle mass and reduces protein catabolism The benefits of combining creatine with protein  Is it better to take creatine before or after a workout? How creatine supplementation may improve brain performance and mental clarity Why exercise is essential for those who want to experience the benefits of creatine for maintaining their bone health The benefits of resistance-band workouts for post-menopausal women Are there any age-related limits for creatine supplementation? Bio: Dr. Darren Candow Dr. Darren Candow, PhD, CSEP-CEP, is Professor and Director of the Aging Muscle and Bone Health Laboratory in the Faculty of Kinesiology and Health Studies at the University of Regina, Canada. The overall objectives of Dr. Candow's research program are to develop effective lifestyle interventions that incorporate nutrition (primarily creatine monohydrate) and physical activity (resistance training), with practical and clinical relevance for improving musculoskeletal aging and reducing the risk of falls and fractures. Dr. Candow has published over 120 peer-refereed journal manuscripts, supervised over 20 MSc and PhD students, and received research funding from the Canadian Institutes of Health Research, Canada Foundation for Innovation, the Saskatchewan Health Research Foundation, the National Institute of Health, and the Nutricia Research Foundation. In addition, Dr. Candow serves on the editorial review boards for the Journal of the International Society of Sports Nutrition, Nutrients, and Frontiers. Connect with Cynthia Thurlow Follow on X ⁠Instagram⁠ ⁠LinkedIn⁠ Check out Cynthia's ⁠website⁠ Submit your questions to ⁠support@cynthiathurlow.com⁠ Connect with Dr. Darren Candow On⁠ Instagram⁠ and X  Previous Episode Mentioned: ⁠Ep. 301 Creatine: The Best Supplement for Better Bones & Brain Health with Darren Candow, PhD, CSEP-CEP⁠

The Complete Paranormal Investigation Handbook w/Richard Palmisano and Peter J. Roe September 21st, 2025 EP: 47 In this episode of ParaTruth: Reborn, Justin and Erik sit down with renowned investigators Richard Palmisano and Peter J. Roe to explore The Complete Paranormal Investigation Handbook. From ghostly encounters to tried-and-true investigative techniques, this conversation pulls back the curtain on what it really takes to research the unknown. Richard and Peter share their years of field experience, offering insights into evidence gathering, case management, and the ethics of working with clients who are experiencing paranormal phenomena. Whether you're a curious listener, an aspiring investigator, or a seasoned researcher, this episode provides practical knowledge and chilling stories that bring the world of paranormal investigation to life. Bios: Peter J. Ros is the assistant director of The Searcher Group (est. 1979), and he serves as director of its subdivision, Mortal Coil Paranormal. He regularly conducts research, promotes the Searcher Group's pro bono services, presents field discoveries, and advocates for vanishing heritage sites. Peter has appeared in a testimonial capacity over two seasons of the Travel Channel's 'Fear the Woods', and he is the author of 'Haunted Town Halls' (Quagmire Press, 2018). Richard Palmisano launched the Searcher Group in 1979, making it Canada's oldest paranormal investigation company. In 2011, Richard founded the Canadian Institute of Parapsychology, dedicated to education regarding life after death, ghosts, and hauntings. Several of Richard's published works have been featured in nationally televised documentaries, and the Searcher Group has also been featured in the United Church Observer (now Broadview) and Reader's Digest.

We spoke to two researchers who disagree about the answer to this question. But they do agree about why it's so hard to answer to begin with. Guests: Dylan Scott, senior correspondent at Vox; Kenneth Mukamal, physician and academic researcher at the Beth Israel Deaconess Medical Center; Timothy Naimi, director of the University of Victoria's Canadian Institute for Substance Use Research For show transcripts, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠vox.com/unxtranscripts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠For more, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠vox.com/unexplainable⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠And please email us! ⁠⁠⁠unexplainable@vox.com⁠⁠⁠We read every email.Support Unexplainable (and get ad-free episodes) by becoming a Vox Member today: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠vox.com/members⁠⁠⁠⁠⁠⁠⁠⁠Thank you! Learn more about your ad choices. Visit podcastchoices.com/adchoices

This and all episodes at: https://aiandyou.net/ .     I'm talking with Megan Peters, who researches thinking about thinking, or metacognition. She is an Associate Professor in the UC Irvine Department of Cognitive Sciences, studying how the brain represents and uses uncertainty, focusing on how these abilities support metacognitive evaluations of the quality of our decisions. She's a Fellow in the UCI Center for the Neurobiology of Learning and Memory, the UCI Center for Theoretical Behavioral Sciences, and the Canadian Institute for Advanced Research (CIFAR) Brain Mind & Consciousness program. She's also President and Co-founder of Neuromatch, an educational platform serving over 30,000 students in over 120 countries across computational neurosciences, deep learning, computational climate science, and neuroAI. In our conclusion, we talk about Turing Tests, measuring the brain, the Haunted Mansion, some cool experiments on brains, and… cats. All this plus our usual look at today's AI headlines. Transcript and URLs referenced at HumanCusp Blog.            

This and all episodes at: https://aiandyou.net/ . Have you ever thought about thinking? That's called metacognition, and Megan Peters thinks about that, a lot. She is an Associate Professor in the UC Irvine Department of Cognitive Sciences, researching how the brain represents and uses uncertainty, focusing on how these abilities support metacognitive evaluations of the quality of our decisions. She's a Fellow in the UCI Center for the Neurobiology of Learning and Memory, the UCI Center for Theoretical Behavioral Sciences, and the Canadian Institute for Advanced Research (CIFAR) Brain Mind & Consciousness program. She's also President and Co-founder of Neuromatch, an educational platform serving over 30,000 students in over 120 countries across computational neurosciences, deep learning, computational climate science, and neuroAI. We get really meta here: talking about thinking about thinking,  how we build models of the world, how language shapes our thinking, whether AI is doing metacognition in its chains of thought, statistical learning in AIs and humans, consciousness in humans and animals and AIs, and theories of consciousness. All this plus our usual look at today's AI headlines. Transcript and URLs referenced at HumanCusp Blog.            

The Famine of 1932–1933 in Ukraine: An Anatomy of the Holodomor (CIUS Press, 2018) is a distillation of thirty years of study of the topic by one of Ukraine's leading historians. In this account, Stanislav Kulchytsky ably incorporates a vast array of sources and literature that have become available in the past three decades into a highly readable narrative, explaining the motives, circumstances and course of this terrible crime against humanity. As the author shows, the Holodomor was triggered by the Bolshevik effort to build a communist socioeconomic order in the Soviet Union. For the peasant majority of the population, this meant the forcible collectivization of individual farms, the seizure of livestock and farm implements, and the conversion of independent farmers into agricultural laborers. Excessive requisitioning of grain and other foodstuffs in the collectivization drive led to famine and deaths in grain-producing regions of the USSR by early 1932. In Ukraine, punitive measures authorized by the Kremlin's top leadership greatly worsened the famine in late 1932 and turned it into the Holodomor, which claimed more than three million lives in the first half of 1933. Identifying key events and decisions that produced the Holodomor, Kulchytsky analyzes economic and political factors, including the national dimension in Ukraine. The book begins with the author's address to the reader, presenting his view of the Holodomor as genocide. In addition to the main text, the volume includes a preface, afterword, glossary, list of abbreviations and acronyms, bibliography, and a short essay on the author and his writings. The Famine of 1932-1933 in Ukraine: An Anatomy of the Holodomor was prepared for publication by the Holodomor Research and Education Consortium (HREC) of the Canadian Institute of Ukrainian Studies, Faculty of Arts, University of Alberta. HREC undertook the translation of Stanislav Kulchytsky's monograph Ukraïns'kyi holodomor v konteksti polityky Kremlia pochatku 1930 rr. as part of its efforts to make available in English seminal works by Ukrainian scholars of the Holodomor. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

The Famine of 1932–1933 in Ukraine: An Anatomy of the Holodomor (CIUS Press, 2018) is a distillation of thirty years of study of the topic by one of Ukraine's leading historians. In this account, Stanislav Kulchytsky ably incorporates a vast array of sources and literature that have become available in the past three decades into a highly readable narrative, explaining the motives, circumstances and course of this terrible crime against humanity. As the author shows, the Holodomor was triggered by the Bolshevik effort to build a communist socioeconomic order in the Soviet Union. For the peasant majority of the population, this meant the forcible collectivization of individual farms, the seizure of livestock and farm implements, and the conversion of independent farmers into agricultural laborers. Excessive requisitioning of grain and other foodstuffs in the collectivization drive led to famine and deaths in grain-producing regions of the USSR by early 1932. In Ukraine, punitive measures authorized by the Kremlin's top leadership greatly worsened the famine in late 1932 and turned it into the Holodomor, which claimed more than three million lives in the first half of 1933. Identifying key events and decisions that produced the Holodomor, Kulchytsky analyzes economic and political factors, including the national dimension in Ukraine. The book begins with the author's address to the reader, presenting his view of the Holodomor as genocide. In addition to the main text, the volume includes a preface, afterword, glossary, list of abbreviations and acronyms, bibliography, and a short essay on the author and his writings. The Famine of 1932-1933 in Ukraine: An Anatomy of the Holodomor was prepared for publication by the Holodomor Research and Education Consortium (HREC) of the Canadian Institute of Ukrainian Studies, Faculty of Arts, University of Alberta. HREC undertook the translation of Stanislav Kulchytsky's monograph Ukraïns'kyi holodomor v konteksti polityky Kremlia pochatku 1930 rr. as part of its efforts to make available in English seminal works by Ukrainian scholars of the Holodomor. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/genocide-studies

The Famine of 1932–1933 in Ukraine: An Anatomy of the Holodomor (CIUS Press, 2018) is a distillation of thirty years of study of the topic by one of Ukraine's leading historians. In this account, Stanislav Kulchytsky ably incorporates a vast array of sources and literature that have become available in the past three decades into a highly readable narrative, explaining the motives, circumstances and course of this terrible crime against humanity. As the author shows, the Holodomor was triggered by the Bolshevik effort to build a communist socioeconomic order in the Soviet Union. For the peasant majority of the population, this meant the forcible collectivization of individual farms, the seizure of livestock and farm implements, and the conversion of independent farmers into agricultural laborers. Excessive requisitioning of grain and other foodstuffs in the collectivization drive led to famine and deaths in grain-producing regions of the USSR by early 1932. In Ukraine, punitive measures authorized by the Kremlin's top leadership greatly worsened the famine in late 1932 and turned it into the Holodomor, which claimed more than three million lives in the first half of 1933. Identifying key events and decisions that produced the Holodomor, Kulchytsky analyzes economic and political factors, including the national dimension in Ukraine. The book begins with the author's address to the reader, presenting his view of the Holodomor as genocide. In addition to the main text, the volume includes a preface, afterword, glossary, list of abbreviations and acronyms, bibliography, and a short essay on the author and his writings. The Famine of 1932-1933 in Ukraine: An Anatomy of the Holodomor was prepared for publication by the Holodomor Research and Education Consortium (HREC) of the Canadian Institute of Ukrainian Studies, Faculty of Arts, University of Alberta. HREC undertook the translation of Stanislav Kulchytsky's monograph Ukraïns'kyi holodomor v konteksti polityky Kremlia pochatku 1930 rr. as part of its efforts to make available in English seminal works by Ukrainian scholars of the Holodomor. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/eastern-european-studies

Dr. Sumanta (Monty) Pal and Dr. Arielle Elkrief discuss the clinical relevance of the gut microbiome in cancer immunotherapy and the importance of antibiotic stewardship, as well as interventions currently being explored to treat gut dysbiosis and optimize immunotherapy response. TRANSCRIPT Dr. Sumanta (Monty) Pal: Hi everyone, I'm Dr. Monty Pal, welcoming you to the ASCO Daily News Podcast. I'm a medical oncologist. I'm a professor and vice chair of academic affairs at the City of Hope Comprehensive Cancer Center in Los Angeles.  Today we're here to discuss one of my favorite topics, which is the gut microbiome. It's almost hard to avoid the gut microbiome nowadays if you look at medical literature within oncology. It's an emerging phenomenon, but there are a couple of individuals that I would really define as pioneers in the field. And one of them is actually with me today, Dr. Arielle Elkrief, to discuss the clinical relevance of the gut microbiome, particularly amongst patients receiving immunotherapy, although I imagine our conversation today will take many twists and turns. Arielle is an assistant professor and clinician scientist in the Department of Oncology at the University of Montreal, and she is co-director of the CHUM Microbiome Center there.  FYI for the listeners, we have our full disclosures in the transcript of this episode.  Arielle, thank you so much for joining us today. Dr. Arielle Elkrief: Thanks so much, Monty. This is going to be amazing. Dr. Sumanta (Monty) Pal: Well, I have to tell you what sort of inspired me to bring you on as a guest. It was one of many things, but it was this really terrific ASCO Educational [Book] article that you wrote. Now, I have to tell you, I've read all the articles sort of cover to cover in the book, and they're always a wonderful primer, so if our audience is studying for board research or something of that sort, it's a terrific resource to go through. I have to tell you, this piece on the gut microbiome that you wrote is nothing short of a masterpiece. If you read this cover to cover, it's actually going to give you, I think, a sense of the current state and future state of the field. I wanted to start by just sort of beginning with sort of the origin story for a lot of this, which is this association between the gut microbiome and immunotherapy response. This takes us back several years to this pivotal series of papers in Science. Maybe you could walk our audience through that. Dr. Arielle Elkrief: Absolutely. Well, thank you so much for your kind words about the ASCO [Educational] Book. It was a team effort with a lot of key opinion leaders in the field, so I'm really glad to learn that you've liked it.  Moving backwards in terms of how we came to understand that the gut microbiome is essential to priming a response to cancer immunotherapy actually goes back to 2015 and seminal papers that looked at what happens when we take mice that are germ-free mice that have never been exposed to a microbiome. These are mice that are born by cesarean section and essentially live in a bubble. And when we give those mice tumors and treat them, in the first papers with anti-CTLA-4 treatment, we realized that these antibodies don't work at all. And that was the first observation that the presence of a gut microbiome was essential to mounting an anti-cancer immune response. When we supplemented those same mice with beneficial bacteria or feces from responder patients, we were able to restore the response to immunotherapy. And so those were really the first preclinical observations that made us understand the critical role of the microbiome in immunotherapy response. Moving a little bit in the future, we examined the fecal microbiome composition using shotgun metagenomic sequencing in different cohorts of patients with solid tumors, namely lung cancers, kidney cancers, and also skin tumors like melanoma, and found that patients who responded to immunotherapy had a distinct microbiome that was characterized by beneficial bacteria compared to patients who experienced resistance to immunotherapy that had a dysbiotic or diseased microbiome. Dr. Sumanta (Monty) Pal: So, you know, it's interesting, these techniques that we're using to sequence the gut, they're a little bit different. So I wonder if you can give the audience a quick primer on these techniques that you're so well versed in, shotgun metagenomic sequencing, 16S rRNA sequencing. If you had to describe this in 30 seconds, which is a tall task, how would you do that? Dr. Arielle Elkrief: That's a tall task. Much of what we know about the microbiome initially came from a technique called 16S rRNA sequencing. This is a technique that amplifies the 16S region and basically tells you at the genus level what's going on at the level of bacterial composition. This technique is fast, relatively cheap, and can be performed on a laptop computer, which is excellent. The problem is that it's prone to a lot of technical variations. Different primers might give you different results, and you're really limited at the genus resolution. You can't get a good resolution in terms of species, and we're learning that different species from the same genus might have different physiological properties, and the same thing goes at the strain level. So when we really zone in and look at inter-species changes, we're seeing that these actually have specific functions in the host. So that brings us to metagenomic sequencing, which is a whole genome sequencing, next-generation sequencing based method that looks at the whole composition and gives you information not only on bacteria, but you might also get fungal and viral properties. You can zoom in on the strain level. You can also get functional output, so we can examine what the metabolic properties of specific species or strains might look like. The negative aspects of shotgun metagenomic sequencing is that it takes a lot of computational power in order to analyze the results and it might take a little bit longer. And certainly, within the clinical setting, not something that's feasible yet.  And that brings us to more novel point-of-care biomarker tools that we've collaborated in developing along with Dr. Laurence Zitvogel and Dr. Lisa Derosa at Gustave Roussy, that learning from the shotgun metagenomics results designed a probe using quantitative PCR which looks for this specific bacteria we know to be important and developed a ratio of harmful bacteria to beneficial bacteria. This is called the TOPOSCORE, and it actually is able to predict quite nicely the response to immunotherapy using a stool sample and a really good turnaround time of almost 72 hours. Dr. Sumanta (Monty) Pal: That was a perfect overview and a lot of information in a short amount of time. It also makes you take out your high school biology textbooks, doesn't it, to understand that the bacterial ribosome, right, is a different size and shape, and that's what we're sequencing here. But these techniques I think are incredibly important, and I'm glad you actually discussed this, this RT-PCR based strategy of calculating the TOPOSCORE. It lends itself to this phenomenon of dysbiosis, and I think for our audience, that's going to be an important term to understand as time goes on. There's the normal healthy gut and then there's this phenomenon of dysbiosis, which is, I guess, simply put, an unhealthy gut. But tell us about, you know, how often you see dysbiosis in a cancer patient, maybe versus a normal healthy adult. Dr. Arielle Elkrief: So, I think we can split up your question into two parts. One is we know from cohort studies and population level-based studies that the microbiome of patients with cancer is distinct from healthy patients or healthy people. And we know that because of the global composition. We also think that there are diversity metrics that lend themselves to being described as dysbiotic. But we do know that the microbiome of people with cancer is distinct from healthy volunteers. That's the first point.  In terms of how frequently dysbiosis occurs in patients with cancer, it's not very well defined. We know that even among healthy people, there is a certain level of dysbiosis. Laurence in her talk mentioned that to be about 10% to 20%. And the other fascinating component is that when we're thinking about dysbiosis and the cancer associated microbiome, in terms of the species that are enriched, it's quite striking that a lot of these dysbiotic or negative bacteria are also found to be enriched in patients with metabolic disease, like cardiovascular disease, for example. And so it's unclear if dysbiosis is the cause or consequence, but there definitely seems to be a general pattern of disease when looking at the microbiome compared to healthy people. Dr. Sumanta (Monty) Pal: That's interesting. So, I'll tell you, my second favorite portion of your article, and I'll tell you my favorite portion as well in the context of this podcast, but my second favorite part was the section around antibiotic stewardship. You know, the utilization of antibiotics in a very pragmatic fashion amongst our patients. Can you describe why that's so critical in the context of the microbiome? Dr. Arielle Elkrief: Antibiotics can disrupt the gut microbiome composition. We know this from mouse studies, but also cohort studies of patients that are exposed to antibiotics. And most importantly, we know that patients who are exposed to antibiotics, either before or during the immunotherapy period, have significantly worse progression-free survival and overall survival to immunotherapy. And this is true for immunotherapy in the monotherapy setting, but also when combined with chemotherapy. What's striking is that when we look at patients who are just treated with chemotherapy, we don't see the negative outcome of antibiotics on outcome and progression-free survival and overall survival, suggesting that the negative impact of antibiotics on outcomes is really specific to immunotherapy backbones. The other important point is that this negative signal is maintained even after adjusting for standard prognostic variables in the specific malignancies that we're looking at. And then most importantly, at the mechanistic level, we were able to actually pinpoint the mechanism behind this antibiotic related dysbiosis. And we see this with a bloom of negative bacteria which induces a loss of MAd-CAM, which is an endothelial gut checkpoint immune marker, and that causes an efflux of immunosuppressive T cells, which are usually in the gut, to go straight into the tumor where they make the tumor unamenable to an immunotherapy response. And so now we finally have the mechanism as to why antibiotics are harmful and why we need to practice antibiotic stewardship. Dr. Sumanta (Monty) Pal: And just to be clear for the audience, I mean, if a patient needs antibiotics, they need antibiotics. But perhaps it just suggests that, and we have, I suppose, this predilection as oncologists, just for the minor cold or cough or what have you, we maybe should be a little bit more cognizant of whether or not antibiotics are truly necessary. Is that fair? Dr. Arielle Elkrief: Absolutely. So what we're advocating for is antibiotic stewardship, and this is the clear recommendation that we can make. So that means confirming a bacterial infection. If it's there and antibiotics are indicated, to choose the most narrow spectrum for the shortest course and constantly re-evaluate the indication of antibiotics. And of course, we need to work with our colleagues in infectious diseases who've done incredible work in antibiotic stewardship. And all along this process we also need to be mindful of other medications and polypharmacy, such as proton pump inhibitors or narcotics, for example, we think that these other medications which are frequently prescribed in our cancer population can also potentially have negative impacts on the microbiome and immunotherapy response. Dr. Sumanta (Monty) Pal: I think that's a terrific summary and big guidance for the audience.  I promised you I'd tell you my favorite part of your article, and this is this huge table. I think the table is two and a half pages long, if I remember correctly, but it's an awesome table, and I highly recommend our audience to check this out. It lists literally every therapeutic trial for the microbiome under the sun. And so it begins with the approach of fecal microbiota transplant, which I'm going to ask you to tell us about in a second, but it also hinges on a lot of really cool sort of novel therapies, live bacterial products, mixes of different microbial products. Maybe take us through this whole approach of FMT (fecal microbiota transplantation). I actually wasn't aware of the dozens of trials that you listed there in this space. It seems like it's a very active area of research. Dr. Arielle Elkrief: Definitely. So, as you alluded to, FMT or fecal microbiota transplantation is the most well studied and direct way to modify the patient's microbiome. This technique aims to replace the patient's dysbiotic microbiome with that of a healthy microbiome, either from a healthy donor volunteer that's been heavily screened, or from a patient who experienced response to immunotherapy. And, as three landmark studies so far that have been published demonstrated the potential of FMT to reduce primary resistance or secondary resistance to immunotherapy, and this has been in melanoma.  We also recently reported on the results of our FMT-LUMINate trial, which looked at patients with lung cancer and melanoma. Once again, FMT, when combined with immunotherapy was safe and led to a higher proportion of responses than we would normally expect.  We're now also looking at randomized trials that have come out. So the first being the TACITO trial in kidney cancer, which compared FMT plus pembrolizumab and axitinib to placebo in patients with RCC, and again, FMT was safe and feasible and also led to an increased progression-free survival at one year, meeting the study's primary endpoint.  And so, so far, there's a wealth of data really showing the promise of FMT when combined with immunotherapy, and we're now in the process of conducting larger randomized trials, including in melanoma with the CCTG (Canada Cancer Trials Group) in our ME17 or Canbiome2 trial, where we're going to be enrolling 128 patients with metastatic melanoma to receive FMT and standard of care immunotherapy compared to standard of care immunotherapy alone. Dr. Sumanta (Monty) Pal: You're very humble, so I've got to highlight for our audience. This was a mega grant that Arielle received to fund really the largest prospective exploration of FMT that will exist to date. So I'm really excited about that. I wish this was something we could participate in stateside.  Before we jump into the other approach, which is live bacterial products and mixes thereof, where do you see FMT going? I think that one of the perceived challenges with FMT is that it's hard to implement, right? You need to have a really robust framework when it comes to gastroenterology, the preparation's challenging. Is there a way to envision FMT use being more generalized? Dr. Arielle Elkrief: Those are great questions. So we're lucky in Canada to work with pioneers in FMT, Michael Silverman, Saman Maleki, and John Lenehan in London, Ontario, who had this really robust FMT healthy donor screening program, which literally screens for every pathogen under the sun, and we haven't had any problems with feasibility or implementing FMT in Canada. But I think that once we're going to hopefully start doing larger scale, randomized phase three studies, that we might run into problems with scalability. And I think also with regards to reproducibility, and that's the feedback that we're getting from some regulatory authorities, especially at the level of the FDA, where there are some concerns around inter- and intra-donor variability because, of course, we can't guarantee that every fecal sample is going to be the same. So that has really pushed the field to think about other strategies, such as live biotherapeutic products which take modified FMT or bacteria from stools from either healthy donors or from responder patients and basically turn them into drugs that are regulated as drugs and can then be studied in the context of investigational new drugs or products. Dr. Sumanta (Monty) Pal: I like this and, you know, I do think that there's a future for it. We just have to kind of put our heads together and figure out how to get over all of these logistical hurdles, but, you know, I agree, I think your group and others have demonstrated, especially with this trial that you're fanning out all throughout Canada, that it can potentially be done.  This is a topic that could probably go on for another couple of hours, right, especially based on the size of the table that you put together in this brilliant article, but tell us about live bacterial products or LBPs, as we call them these days. What's the current status, what's the future there? And maybe I'll give you less than two minutes here, although again, I realize it's a two-hour topic. Dr. Arielle Elkrief: You're probably better suited to speak about that because you've been one of the pioneers in terms of this. So we can think about LBPs in terms of single strain organisms, like CBM588 for an example, which your group did some amazing work in showing that, in a randomized setting, that this led to better responses than we would expect compared to just work with controls. We also know that LBPs can have multiple strains, up to 30. We're collaborating with a company called Cannabis Bioscience that is actually working on much larger communities of consortia. And so we're really excited about the direction that that's taking in terms of taking these LBPs and developing them from the drug perspective. In addition to LBPs, we know that there are other ways that we can change the microbiome, notably prebiotics, which are compounds which can have a beneficial impact on the microbiome. And one of these is camu camu, which I know your group is leading a clinical trial looking at camu camu and kidney cancer, and we're excited to see how that compares to FMT or LBPs, because that might be a potentially scalable alternative. Dr. Sumanta (Monty) Pal: That's awesome. What a terrific overview, and that was less than two minutes. I don't know how you did it. That's terrific.  Arielle, this has been such an insightful conversation. I just want to thank you for, again, a terrific article in the ASCO Educational Book. I highly recommend all of our listeners to go there and check it out, and also for sharing all these terrific insights on the podcast today. Dr. Arielle Elkrief: Thank you so much, Monty. Dr. Sumanta (Monty) Pal: And thanks to our listeners, too. If you value the insights that you heard today on the ASCO Daily News Podcast, please rate, review, and subscribe wherever you get your podcasts. Thanks, everyone. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers:    Dr. Sumanta (Monty) Pal  @montypal Dr. Arielle Elkrief Follow ASCO on social media:     @ASCO on Twitter    ASCO on Bluesky   ASCO on Facebook     ASCO on LinkedIn     Disclosures:    Dr. Sumanta (Monty) Pal:   Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview  Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical  Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis  Dr. Arielle Elkrief: Honoraria: AstraZenica, Bristol-Myers Squibb, Merck, EMD Serono Consulting or Advisory Role: Bristol-Myers Squibb Research Funding (Inst.): Kanvas Bioscience, AstraZeneca, Merck Other Relationship: Royal College of Surgeons and Physicians of Canada, Cedar's Cancer Center (Henry R. Shibata Fellowship), Canadian Institutes of Health Research (CIHR)

This episode of the Amazing Cities and Towns Podcast, Jim Hunt interviews Chelsey Jersak, Founder of Situate   ·       A candid conversation about urban planning and and, much more   7 Steps to an Amazing City:   Attitude Motivation Attention to Detail Zing Inclusiveness Neighborhood Empowerment Green Awareness   Thanks for listening and look forward to having you join us for the next episode.   Links Mentions During Show:  https://situateinc.ca/ ·       www.AmazingCities.org ·       www.AmazingCities.org/podcast to be a guest on the podcast   About   Chelsey Jersak is the founder and principal of Situate, an urban planning consulting firm in Edmonton offering rezoning, permitting, subdivision and strategic advisory services for infill projects across the city. Chelsey became familiar with IDEA soon after the organization formed, back when she was a city planner with the City of Edmonton. After moving to the private sector and starting Situate, Chelsey enthusiastically joined the IDEA board and has since filled many roles, including chairing the community relations and policy subcommittees, and serving as vice president, president and now past president.  Chelsey's area of focus on the board is strategy; she supports the organization in scaling up its oomph and impact through regular strategic planning sessions and tangible objectives and key results. She's also passionate about connecting the dots between urban redevelopment, climate action, and social wellbeing. Chelsey holds a Bachelor's degree in Regional and Urban Development and a Master's degree in Human Geography. She is a Registered Professional Planner and a member of the Canadian Institute of Planners. Her hobbies include downhill skiing and partner dancing, particularly an obscure Brazilian dance called Zouk. She also has an insatiable love for dill pickles.    About Your Host, Jim Hunt: Welcome to the “Building Amazing Cities and Towns Podcast” … The podcast for Mayors, Council Members, Managers, Staff and anyone who is interested in building an Amazing City.   Your host is Jim Hunt, the author of “Bottom Line Green, How American Cities are Saving the Planet and Money Too” and his latest book, “The Amazing City - 7 Steps to Creating an Amazing City”   Jim is also the former President of the National League of Cities, 27 year Mayor, Council Member and 2006 Municipal Leader of the Year by American City and County Magazine.   Today, Jim speaks to 1000's of local government officials each year in the US and abroad.   Jim also consults with businesses that are bringing technology and innovation to local government.   Amazing City Resources:   Buy Jim's Popular Books: ·       The Entrepreneurial City: Building Smarter Governments through Entrepreneurial Thinking:   https://www.amazingcities.org/copy-of-the-amazing-city   ·       The Amazing City: 7 Steps to Creating an Amazing City:   https://www.amazingcities.org/product-page/the-amazing-city-7-steps-to-creating-an-amazing-city   ·       Bottom Line Green: How America's Cities and Saving the Planet (And Money Too)  https://www.amazingcities.org/product-page/bottom-line-green-how-america-s-cities-are-saving-the-planet-and-money-too   FREE White Paper: ·       “10 Steps to Revitalize Your Downtown”  www.AmazingCities.org/10-Steps   Hire Jim to Speak at Your Next Event: ·       Tell us about your event and see if dates are available at www.AmazingCities.org/Speaking   Hire Jim to Consult with Your City or Town: ·       Discover more details at https://www.amazingcities.org/consulting   Discuss Your Business Opportunity/Product to Help Amazing Cities: ·       Complete the form at https://www.amazingcities.org/business-development   A Special Thanks to Bearing Advisors for the support of this podcast:  www.BearingAdvisors.Net      

What if the sudden mood changes, crushing fatigue, or unexpected anxiety you're experiencing aren't just stress or part of getting older, but signs of depression linked to perimenopause? In this episode, ADAA member expert and psychiatrist Dr. Crystal Clark joins host Gabe Howard to shine a light on one of the most overlooked mental health issues affecting women: the biological storm of perimenopause and its deep connection to depression and anxiety. They break down why up to 40% of women experience depression during this hormonal transition — and why so many are told to just “tough it out.”You'll learn the early warning signs to watch for, the science behind hormonal shifts and mental health, and why dismissing symptoms as “normal aging” could be harmful. Plus, they explore how therapy, medication, lifestyle shifts, and even hormone therapy can play a role in recovery. Whether you're in perimenopause, supporting someone who is, or just want to understand this life stage, this episode delivers clarity, compassion, and concrete takeaways. This episode has been sponsored by the Anxiety and Depression Association of America (ADAA). Our guest, Dr. Crystal Clark, is an internationally recognized psychiatrist in women's mental health. She holds a Canada Research Chair in Reproductive Mental Health. She is an Associate Professor in the Department of Psychiatry at the University of Toronto, and the Associate Head of Research at Women's College Hospital. Dr. Clark specializes in mood and anxiety disorders specifically across the reproductive life span (from menstruation to peri and post menopause). Dr. Clark's research has focused on psychopharmacology for the treatment of perinatal mood disorders.  Her research aims to prevent the recurrence of illness during pregnancy and postpartum through safe dose optimization and personalized dosing strategies. Her research also aims to develop identification and prevention strategies for all persons with perinatal mood and anxiety disorders including those who are disproportionately impacted by these disorders. Dr. Clark's research has been funded by the Canadian Institute of Health Research and the National Institutes of Health.  Among Dr. Clark's many leadership roles, she is a past president of the Marcé of North America, an organization dedicated to advancing perinatal mental health care, and she serves on the board of directors of Marcé International. She has been a contributor to large initiatives in Canada and the US to improve perinatal mental health in North America. As a thought leader, Dr. Clark is a thought leader and has been a contributor by several media outlets including CBS, NPR, NY Times, and Chicago Tonight regarding issues related to perinatal mental health. Our host, Gabe Howard, is an award-winning writer and speaker who lives with bipolar disorder. He is the author of the popular book, "Mental Illness is an Asshole and other Observations," available from Amazon; signed copies are also available directly from the author. Gabe is also the host of the "Inside Bipolar" podcast with Dr. Nicole Washington. Gabe makes his home in the suburbs of Columbus, Ohio. He lives with his supportive wife, Kendall, and a Miniature Schnauzer dog that he never wanted, but now can't imagine life without. To book Gabe for your next event or learn more about him, please visit gabehoward.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

C-5 summit in Gatineau could set the the tone of government-Indigenous relations — for the rest of Mark Carney's time as Prime Minister. Brazil's Congress passes bill that drastically weakens the country's environmental safeguards. Canada's largest federal public sector union disputes Pierre Poilievre's account of why he lost his riding in the last election. United States senate passes President Donald Trump's recessions package, paving way for cuts to foreign aid and public broadcasting. Wildfire evacuees in Manitoba waiting for when they can return home. New report by Canadian Institute for Health Information finds more Canadians getting hurt by e-scooters. "Pretty Little Baby" singer Connie Francis dies at 87.

In this episode of YourForest Podcast, host Matthew Kristoff is joined by Kelly Cooper, founder of the Free to Grow in Forestry initiative, and Greg Herringer, chair of the Canadian Institute of Forestry's DEI leadership team. Through honest and eye-opening conversation, they unpack why change is so difficult, highlighting deep-rooted resistance, fear of change, and power dynamics that hold progress back. Kelly shares her personal experience of being excluded from the very DEI work she was leading, while Greg reflects on how bias shows up in both personal and professional spaces.

AiArthritis is bringing you along for the journey as part of our Go With Us! Program, this time straight from the EULAR 2025 in Barcelona. In this episode, we're spotlighting key research updates that matter most to patients living with AiArthritis diseases. Our 'co hosts, Leila, Tiffany, Deb, and Eileen, are on the ground at EULAR, reporting back with fresh insights into patient-prioritized topics. You'll hear how nutrition and microbiome research is shifting how we understand inflammation and autoimmune risk, why CAR T-cell therapy is creating buzz as a potential path to long-term remission, and what new research is saying about enthesitis in spondyloarthritis. Plus, learn more about the debate on the pros and cons of cannabis use for chronic pain management. This episode brings the conference experience straight to you with a focus on what it all means for real patients.   Donate to Support the Show: www.aiarthritis.org/donate   Episode Highlights: Insights from new research linking diet and gut health to autoimmune activity What CAR T-cell therapy could mean for the future of treatment A deeper look at enthesitis and how it's being understood in spondyloarthritis How the medical community is reevaluating the use of cannabis in treatment plans.   Links & Resources Go With Us! To EULAR 2025 YouTube Playlist: https://www.youtube.com/playlist?list=PLZW5ZyvNnYl3wsrI7usV495JH2OMfUdzN Have questions about this episode or topics you want to hear us bring to the table? Email us at podcast@aiarthritis.org  Follow AiArthritis on all social media platforms @IFAiArthritis Sign up for our Monthly AiArthritis Voices 360 Talk Show newsletter! HERE   Connect with our Co Hosts:   Leila is the Health Education Manager at the International Foundation for AiArthritis. She is a person living with Lupus and Sjögren's disease. She is passionate about inclusion and diversity in health education and meeting individuals where they are at in order to learn in a way that resonates with them.   Eileen Davidson is a rheumatoid arthritis patient advocate from Vancouver Canada. She volunteers with the Arthritis Research Canada patient advisory board and the Canadian Institute of Health Research - Institute of Musculoskeletal Health and Arthritis patient engagement research ambassador, among others. When not advocating she is writing about her experience with arthritis through Creaky Joints, Healthline, Chronic Eileen or can be found being a mom to her son Jacob.   Tiffany Westrich-Robertson is the CEO at AiArthritis (International Foundation for Autoimmune & Autoinflammatory Arthritis) and uses her professional expertise in mind-mapping and problem solving to help others, like her, who live with AiArthritis diseases work in unison to identify and solve unresolved community issues.   Deb Constien is a medically retired Registered Dietitian and a Representative for AiArthritis with Rheumatoid Arthritis. Deb is also on the Advisory Council for WREN- Wisconsin Research Education Network and a Patient Family Advisor- PFA on an International PCORI research study for ACP- Advanced Care Planning.

Even in the name of love, we can justify hatred, even murder, of the other. But why do we hate others? Scholars have identified a list of 10 reasons why one group may hate another group. They also have suggestions on how to break the cycle of hate. Guests in this episode are scholars from the Canadian Institute for Advanced Research (CIFAR):Prerna Singh, professor of political science, Brown University, U.S.Victoria Esses, professor of psychology, Western University, London, Ontario Stephen Reicher, professor of social psychology, University of St. Andrews, Scotland

https://vimeo.com/1079953899?share=copy When we are inundated with the shadows and the dense frequencies of the human consciousness and the unconscious and that's all we're seeing is that shadow coming up into the light.  We might forget who we are.  We might get lost in that shadow and start to get mired in it. How do we break free? How do we transmute, alchemize, bring love to everything we're witnessing?  Today we have John Stringer with us, who is a life teacher, a song writer, a healer, and brings so many gifts to the world.  I invite you to join us as we have a conversation about navigating these times with love! John Stringer began receiving direct from Source / Spirit on-demand (aka channeling) in 2008.  John Stringer has written and recorded several albums (including a co-written top 10 best-selling Billboard chart hit single) and has performed throughout the world. His music has been featured on major network television and he has also appeared in national print ads. John Stringer speaks publicly, writes music & lyrics; serves others in group, remote & one-on-one channeling sessions; and writes content for his websites and books to share the teachings he continues to receive. Watch or listen to the show for practical tips on how to break from the shadow and navigate these times with love. You're Invited! CHECK OUT: Unlock Your Songwriting Challenge https://www.johnstringerinc.com/5-day-uysgc-grad-offer/ LISTEN: Awakened Pillow Talk Podcast https://www.healingartsmgmt.com/podcasts/   JOHN STRINGER BIO John is a life teacher, speaker, Billboard-charting singer-songwriter, healer, and award-winning International Bestselling author. He currently serves as Founder of PolyPlat Records, Partner at Healing Arts Management , Founder of ConsciousSongwriting.com, Partner at ConsciousSongwritingRetreat.com, Co-host of Awakened Pillow Talk podcast, host of The Alignment Podcast, Co-Founder of MasterMomentMakers.com, and he served as a True Collaboration℠ leader at BandingPeopleTogether.com. He now travels extensively, speaking and sharing his uplifting and healing music and message through songs from both his debut solo album, “Limitless Love & Light,” which features the 2017 Posi Award-nominated song, “That's Love;”  and his follow up album, “Moment to Moment;” along with channeled teachings found in his book, The Abundance Vibration: A Guide to Alignment and his most recent award-winning, international bestselling book, the INside effects: How the Body Heals Itself, Volume 2. His music is currently being used for the theme songs at the Canadian Institute for Natural Integrative Medicine, Life University, the City of Hapeville, Special Needs Certified, Orlando Pranic Healing Centers and other wonderful organizations spreading love in their own way. Between enjoying his wonderful wife and children in Atlanta, GA, John continues sharing his life and following where Source leads. Life's Goal: To be Limitless Love & Light from Moment to Moment LINKS Web: https://www.johnstringerinc.com/ Podcast: https://www.healingartsmgmt.com/podcasts/ Facebook: https://www.facebook.com/johnstringer1111/ Instagram: https://www.instagram.com/john.h.stringer/ LinkedIn: https://www.linkedin.com/in/jstringer/ YouTube: https://www.youtube.com/user/JohnHStringer   YOUR GUIDE TO SOUL NECTAR: KERRI HUMMINGBIRD I love mentoring women to rewrite the story of their lives through inner transformation, connection to essence, remembrance of purpose, and realignment to authenticity and truth. If you don't want to settle for anything less than a life of passion and purpose, book a Discovery Call and let's talk! Schedule today! http://bit.ly/2CpFHFZ FREE GIFT: The Love Mastery Game, an oracle for revealing your soul's curriculum in every day challenges. http://www.kerrihummingbird.com/play JOIN SOUL NECTAR TRIBE! https://kerrihummingbird.com/membership